Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
5.54
-0.31 (-5.30%)
Feb 21, 2025, 4:00 PM EST - Market closed
Acrivon Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$22.40
Upside
+304.33%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 31, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $28 → $27 | Buy | Maintains | $28 → $27 | +387.36% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +297.11% | Nov 14, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $17 | Buy | Reiterates | $17 | +206.86% | Sep 16, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Hold → Strong Buy Upgrades $16 | Hold → Strong Buy | Upgrades | $16 | +188.81% | Sep 16, 2024 |
| BMO Capital | BMO Capital | Buy Reiterates $25 → $28 | Buy | Reiterates | $25 → $28 | +405.42% | Sep 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +297.11% | Sep 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +297.11% | Aug 13, 2024 |
| BMO Capital | BMO Capital | Buy Reiterates $25 | Buy | Reiterates | $25 | +351.26% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $22 | Strong Buy | Maintains | $20 → $22 | +297.11% | May 14, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 29, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $18 → $25 | Buy | Maintains | $18 → $25 | +351.26% | Apr 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +261.01% | Apr 25, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $14 → $17 | Buy | Maintains | $14 → $17 | +206.86% | Apr 25, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $26 → $30 | Buy | Maintains | $26 → $30 | +441.52% | Apr 25, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $18 → $14 | Strong Buy | Maintains | $18 → $14 | +152.71% | Apr 5, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.